GDF-15 and mtDNA Deletions Are Useful Biomarkers of Mitochondrial Dysfunction in Insulin Resistance and PCOS
International Journal of Molecular Sciences · 10.10.2024 · 25 (20) · 10916
DOI: 10.3390/ijms252010916 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.10.2024. Verfasst von Vera Varhegyi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Genomic Medicine and Rare Disorders, Semmelweis University, 1085 Budapest, Hungary. Hauptthemen laut MEDLINE: Growth Differentiation Factor 15, Polycystic Ovary Syndrome, Insulin Resistance, DNA, Mitochondrial. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research, Development and Innovation Office, Hungarian Society of Hypertension, Semmelweis University.
Abstract (Originalsprache)
There is no literature available about the growth differentiation factor-15 (GDF-15) biomarker in combination with mitochondrial DNA (mtDNA) deletions in insulin resistance (IR), and polycystic ovary syndrome (PCOS); however, it would be useful to achieve optimal metabolic status and improve pregnancy success. In this study, the role of GDF-15 and mtDNA deletions as biomarkers in the pathogenesis of IR and PCOS was investigated. In our study, 81 female patients who were treated for IR and/or PCOS and 41 healthy controls were included. GDF-15 levels in patients showed a marked increase compared to controls. Elevated GDF-15 levels were found in 12 patients; all of them had a BMI > 25 kg/m2, which is associated with reactive hyperinsulinemia. The presence of mitochondrial dysfunction was mainly observed in the IR-only subgroup. The increase in plasma levels of GDF-15 and the prevalence of mtDNA deletions is directly proportional to body mass index. The more marked metabolic abnormalities required more intensive drug therapy with a parallel increase in plasma GDF-15 levels. Elevated levels of GDF-15 and the presence of mitochondrial DNA deletions may be a consequence of carbohydrate metabolism disorders in patients and thus a predictor of the process of accelerated aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Genomic Medicine and Rare Disorders, Semmelweis University, 1085 Budapest, Hungary.
- Department of Obstetrics and Gynecology, Semmelweis University, 1085 Budapest, Hungary.
- Department of Physiology, Semmelweis University, 1085 Budapest, Hungary.
- Department of Obstetrics and Gynecology, Albert Szent-Györgyi Clinical Centre, University of Szeged, 6720 Szeged, Hungary.
- Workgroup for Science Management, Doctoral School, Semmelweis University, 1085 Budapest, Hungary.
ORCID-Profile: Aniko Gal
Förderung
- National Research, Development and Innovation Office
- Hungarian Society of Hypertension
- Semmelweis University
- Janos Bolyai Research Scholarship
- National Research, Development, and Innovation Office
- Hungarian Hypertension Society
Zitieren
APA
Varhegyi, V., Modos, A., Trager, D., Gerszi, D., Horvath, E. M., Sipos, M., Acs, N., Molnar, M. J., Varbiro, S., & Gal, A. (2024). GDF-15 and mtDNA Deletions Are Useful Biomarkers of Mitochondrial Dysfunction in Insulin Resistance and PCOS. International Journal of Molecular Sciences, 25(20), 10916. https://doi.org/10.3390/ijms252010916
Vancouver
Varhegyi V, Modos A, Trager D, Gerszi D, Horvath EM, Sipos M, et al. GDF-15 and mtDNA Deletions Are Useful Biomarkers of Mitochondrial Dysfunction in Insulin Resistance and PCOS. International Journal of Molecular Sciences. 2024;25(20):10916. doi:10.3390/ijms252010916
BibTeX
@article{Varhegyi2024,
author = {Varhegyi, Vera and Modos, Anna and Trager, Domonkos and Gerszi, Dora and Horvath, Eszter Maria and Sipos, Miklos and Acs, Nandor and Molnar, Maria Judit and Varbiro, Szabolcs and Gal, Aniko},
title = {GDF-15 and mtDNA Deletions Are Useful Biomarkers of Mitochondrial Dysfunction in Insulin Resistance and PCOS},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {20},
pages = {10916},
doi = {10.3390/ijms252010916}
}
EUVIMED